Featured Research

from universities, journals, and other organizations

Anti-HIV Protein From Blue-green Algae Also Inhibits Ebola Infection

Date:
March 5, 2003
Source:
NIH/National Cancer Institute
Summary:
Researchers have discovered that a bacterial protein known to reduce the ability of the human immunodeficiency virus (HIV) to infect cells also inhibits infection by the Ebola virus. The antiviral protein, known as cyanovirin-N (CV-N), can extend the survival time of Ebola-infected mice, researchers from the National Cancer Institute's Molecular Targets Discovery Program report in a study published in Antiviral Research.

Researchers have discovered that a bacterial protein known to reduce the ability of the human immunodeficiency virus (HIV) to infect cells also inhibits infection by the Ebola virus. The antiviral protein, known as cyanovirin-N (CV-N), can extend the survival time of Ebola-infected mice, researchers from the National Cancer Institute's Molecular Targets Discovery Program report in a study published in Antiviral Research.

The study, done in collaboration with researchers from the U.S. Army Medical Research Institute of Infectious Diseases, the Centers for Disease Control and Prevention, and the National Institute of Diabetes and Digestive and Kidney Diseases, provides important insights into the process of Ebola infection. There is currently no treatment for Ebola infection, which causes severe and often fatal hemorrhagic fever.

CV-N comes from a type of bacterium known as cyanobacterium, or blue-green algae. Its antiviral properties were originally discovered through NCI's Laboratory of Drug Discovery Research and Development in a screening process designed to identify natural materials that act against HIV. CV-N effectively inhibits HIV infection of cells grown in the laboratory.

"CV-N is extremely effective against a broad range of HIV strains," said Barry O'Keefe, Ph.D., of NCI's Center for Cancer Research, one of the authors of the study. It is currently being investigated in the laboratory as a potential topical microbicide to prevent the sexual transmission of HIV.

CV-N inhibits HIV infection by binding to the outside of the virus and physically blocking it from entering cells. The protein is known to attach to a particular sugar molecule on the virus surface, and because similar sugar molecules coat the Ebola virus, researchers hoped CV-N might have the same effect on Ebola that it does on HIV.

Their hypothesis proved to be true when laboratory experiments revealed that CV-N does bind to the sugar molecules on the outside of the Ebola virus and inhibit its ability to infect cells, much as it does with HIV. Furthermore, when researchers injected CV-N into mice prior to infecting the animals with Ebola, then continued to inject CV-N once a day, the onset of visible illness was delayed and the animals survived longer than those not treated with CV-N.

"CV-N is the first molecule known to inhibit Ebola infection by interfering with the virus's ability to enter cells," said O'Keefe. Although researchers believe it is unlikely that CV-N itself will be an effective treatment for Ebola infection, understanding the specific molecules involved in CV-N's interaction with the virus will help clarify the processes necessary for infection. Scientists are optimistic that this knowledge eventually may lead to useful therapies.

###

For more information about cancer, visit NCI's Web site at http://www.cancer.gov .


Story Source:

The above story is based on materials provided by NIH/National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Cancer Institute. "Anti-HIV Protein From Blue-green Algae Also Inhibits Ebola Infection." ScienceDaily. ScienceDaily, 5 March 2003. <www.sciencedaily.com/releases/2003/03/030305081547.htm>.
NIH/National Cancer Institute. (2003, March 5). Anti-HIV Protein From Blue-green Algae Also Inhibits Ebola Infection. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2003/03/030305081547.htm
NIH/National Cancer Institute. "Anti-HIV Protein From Blue-green Algae Also Inhibits Ebola Infection." ScienceDaily. www.sciencedaily.com/releases/2003/03/030305081547.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins